1. Home
  2. HAFN vs AMRX Comparison

HAFN vs AMRX Comparison

Compare HAFN & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAFN
  • AMRX
  • Stock Information
  • Founded
  • HAFN 2012
  • AMRX 2002
  • Country
  • HAFN Singapore
  • AMRX United States
  • Employees
  • HAFN N/A
  • AMRX N/A
  • Industry
  • HAFN
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HAFN
  • AMRX Health Care
  • Exchange
  • HAFN Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • HAFN 2.7B
  • AMRX 2.5B
  • IPO Year
  • HAFN N/A
  • AMRX N/A
  • Fundamental
  • Price
  • HAFN $5.47
  • AMRX $7.83
  • Analyst Decision
  • HAFN Strong Buy
  • AMRX Strong Buy
  • Analyst Count
  • HAFN 1
  • AMRX 4
  • Target Price
  • HAFN $6.50
  • AMRX $11.50
  • AVG Volume (30 Days)
  • HAFN 1.1M
  • AMRX 1.3M
  • Earning Date
  • HAFN 08-27-2025
  • AMRX 08-05-2025
  • Dividend Yield
  • HAFN 16.72%
  • AMRX N/A
  • EPS Growth
  • HAFN N/A
  • AMRX N/A
  • EPS
  • HAFN 1.20
  • AMRX N/A
  • Revenue
  • HAFN $2,631,664,000.00
  • AMRX $2,830,186,000.00
  • Revenue This Year
  • HAFN N/A
  • AMRX $9.92
  • Revenue Next Year
  • HAFN $1.07
  • AMRX $7.39
  • P/E Ratio
  • HAFN $4.38
  • AMRX N/A
  • Revenue Growth
  • HAFN N/A
  • AMRX 13.42
  • 52 Week Low
  • HAFN $3.61
  • AMRX $6.50
  • 52 Week High
  • HAFN $8.26
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • HAFN N/A
  • AMRX 41.51
  • Support Level
  • HAFN N/A
  • AMRX $7.97
  • Resistance Level
  • HAFN N/A
  • AMRX $8.24
  • Average True Range (ATR)
  • HAFN 0.00
  • AMRX 0.19
  • MACD
  • HAFN 0.00
  • AMRX -0.05
  • Stochastic Oscillator
  • HAFN 0.00
  • AMRX 20.37

About HAFN Hafnia Limited Common Shares

Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: